Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new celecoxib clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on celecoxib
- Celebrex In Acute Gouty Arthritis Study
Status: Recruiting, Condition Summary: Arthritis, Gouty - Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Status: Recruiting, Condition Summary: Adenomatous Polyposis Coli - Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen
Status: Active, not recruiting, Condition Summary: Breast Neoplasms - Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"
Status: Active, not recruiting, Condition Summary: Osteoarthritis; Osteoarthritis, Knee; Osteoarthritis, Hip - A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain
Status: Recruiting, Condition Summary: Back Pain - Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
Status: Completed, Condition Summary: Pancreatic Cancer - Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib
Status: Recruiting, Condition Summary: Adenomatous Polyposis Coli - Celecoxib (Celebrex) in the Management of Acute Renal Colic
Status: Recruiting, Condition Summary: Ureteral Calculi - CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)
Status: Recruiting, Condition Summary: Lung Cancer - Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis
Status: Completed, Condition Summary: Spondylitis, Ankylosing - Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
Status: Recruiting, Condition Summary: Head and Neck Cancer - Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer
Status: Active, not recruiting, Condition Summary: Head and Neck Cancer; Lung Cancer - Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
Status: Completed, Condition Summary: Lung Cancer - Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
Status: Active, not recruiting, Condition Summary: Pancreatic Cancer - Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
Status: Recruiting, Condition Summary: Recurrent Respiratory Papillomatosis - Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Status: Active, not recruiting, Condition Summary: Colorectal Cancer - Molecular Targeting of 15-LOX-1 for Apoptosis Induction in Human Colorectal Cancers
Status: Recruiting, Condition Summary: Familial Adenomatous Polyposis - Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
Status: Active, not recruiting, Condition Summary: Squamous Cell Carcinoma - Perioperative Pain Control With Celecoxib (Celebrex) in Total Knee Arthroplasty
Status: Recruiting, Condition Summary: Osteoarthritis - Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
Status: Recruiting, Condition Summary: Colon Cancer; Colorectal Cancer - 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
Status: Recruiting, Condition Summary: Anaplastic Glioma; Glioblastoma Multiforme; Brain Cancer - Efficacy of Celecoxib 200mg in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee
Status: Recruiting, Condition Summary: Osteoarthritis of the Knee - The Effects of Celecoxib on Bone Ingrowth
Status: Not yet recruiting, Condition Summary: Bone Ingrowth; Pain - Celebrex (Celecoxib) Treatment of Laryngeal Papilloma
Status: Recruiting, Condition Summary: Recurrent Respiratory Papilloma - Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Status: Recruiting, Condition Summary: Breast Cancer - Evaluation of Surgically Resected Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib
Status: Completed, Condition Summary: Colorectal Adenoma; Colorectal Carcinoma - Erlotinib With or Without Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Status: Recruiting, Condition Summary: Lung Cancer - Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
Status: Active, not recruiting, Condition Summary: Colorectal Cancer - Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Status: Active, not recruiting, Condition Summary: Colorectal Cancer - A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
Status: Completed, Condition Summary: Neoplasms